Julie Overbaugh wetenschapper
Overbaugh, Julie
VIAF ID: 315189121 (Personal)
Permalink: http://viaf.org/viaf/315189121
Preferred Forms
-
100 0 _
‡a
Julie Overbaugh
‡c
wetenschapper
-
100 1 _ ‡a Overbaugh, Julie
-
100 1 _
‡a
Overbaugh, Julie
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Identification of HIV gp41-specific antibodies that mediate killing of infected cells |
|
| Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population |
|
| Identification of Owl Monkey CD4 Receptors Broadly Compatible with Early-Stage HIV-1 Isolates |
|
| Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission |
|
| Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge |
|
| Incidence and correlates of HIV-1 RNA detection in the breast milk of women receiving HAART for the prevention of HIV-1 transmission |
|
| Increased levels of HIV-1-infected cells in endocervical secretions after the luteinizing hormone surge |
|
| Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission |
|
| The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity |
|
| The influence of hormonal contraceptive use on HIV-1 transmission and disease progression |
|
| Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women |
|
| Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage |
|
| Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1 |
|
| Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants |
|
| Loss to follow-up as a competing risk in an observational study of HIV-1 incidence |
|
| Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment |
|
| Lower risk of resistance after short-course HAART compared with zidovudine/single-dose nevirapine used for prevention of HIV-1 mother-to-child transmission |
|
| Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an Envelope-dependent manner |
|
| Mapping mutational effects along the evolutionary landscape of HIV envelope |
|
| Massively Parallel Profiling of HIV-1 Resistance to the Fusion Inhibitor Enfuvirtide |
|
| Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk |
|
| Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission |
|
| Medication diaries do not improve outcomes with highly active antiretroviral therapy in Kenyan children: a randomized clinical trial |
|
| Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity |
|
| Mother-infant HIV transmission: do maternal HIV-specific antibodies protect the infant? |
|
| Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially |
|
| Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer. |
|
| Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection |
|
| The neutralization sensitivity of viruses representing human immunodeficiency virus type 1 variants of diverse subtypes from early in infection is dependent on producer cell, as well as characteristics of the specific antibody and envelope variant |
|
| Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy |
|
| No evidence for rapid subtype C spread within an epidemic in which multiple subtypes and intersubtype recombinants circulate |
|
| Older age at infection and nulliparity are associated with long-term non-progression in female sex workers infected with non-subtype B HIV-1 |
|
| Oligonucleotide ligation assay detects HIV drug resistance associated with virologic failure among antiretroviral-naive adults in Kenya. |
|
| Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry |
|
| Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality |
|
| Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality |
|
| Performance of the integrated management of childhood illness algorithm for diagnosis of HIV-1 infection among African infants |
|
| Phage-DMS: A Comprehensive Method for Fine Mapping of Antibody Epitopes |
|
| Primary CMV infection: a co-factor HIV-1 disease progression in African infants? |
|
| Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood |
|
| A prospective cohort study of fertility desire, unprotected sex, and detectable viral load in HIV-positive female sex workers in Mombasa, Kenya. |
|
| A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy |
|
| A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A |
|
| Quantification of genital human immunodeficiency virus type 1 (HIV-1) DNA in specimens from women with low plasma HIV-1 RNA levels typical of HIV-1 nontransmitters |
|
| Quotidian changes of genital tract cytokines in human immunodeficiency virus-1-infected women during the menstrual cycle |
|
| A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes |
|
| Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification |
|
| A real-time PCR-based method to independently sample single simian immunodeficiency virus genomes from macaques with a range of viral loads |
|
| Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis |
|
| The Robust Restriction of Zika Virus by Type-I Interferon in A549 Cells Varies by Viral Lineage and Is Not Determined by IFITM3 |
|
| The role of cell-associated virus in mother-to-child HIV transmission |
|
| SARS-CoV-2 Antibody Binding and Neutralization in Dried Blood Spot Eluates and Paired Plasma |
|
| Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies |
|
| Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels |
|
| Sequence variability of the integrase protein from a diverse collection of HIV type 1 isolates representing several subtypes |
|
| Short Communication: A Decrease in Albumin in Early HIV Type 1 Infection Predicts Subsequent Disease Progression |
|
| Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women |
|
| Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments |
|
| Simian immunodeficiency virus variants that differ in pathogenicity differ in fitness under rapid cell turnover conditions |
|
| A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection |
|
| Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity |
|
| Subtype C Is associated with increased vaginal shedding of HIV-1. |
|
| Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire. |
|
| Sustained Responses to Measles Revaccination at 24 Months in HIV-Infected Children on Antiretroviral Therapy in Kenya |
|
| Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition |
|
| Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody response |
|
| The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary TÂ cells |
|
| Transmission of HIV-1 in the face of neutralizing antibodies |
|
| Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancy |
|
| A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry |
|
| Understanding protection from SARS-CoV-2 by studying reinfection |
|
| Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial |
|
| Validation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples |
|
| Vertical Cytomegalovirus Transmission From HIV-Infected Women Randomized to Formula-Feed or Breastfeed Their Infants |
|
| Virological failure in children living with HIV on antiretroviral therapy: correlates and predictive value of clinical measurements and CD4 cell count |
|
| Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women |
|
| A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV |
|
| Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya |
|
| Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trial |
|
| Why we need good mentoring |
|
| Zika Virus Circulates at Low Levels in Western and Coastal Kenya |
|
